138 related articles for article (PubMed ID: 6925983)
1. A follow-up study on chemoimmunotherapy (5-fluorouracil and BCG) in advanced gastric cancer.
Popiela T; Zembala M; Oszacki J; Jedrychowski W
Cancer Immunol Immunother; 1982; 13(3):182-4. PubMed ID: 6925983
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemoimmunotherapy for gastric carcinoma.
Makowka L; Falk RE; Ambus U; Bugala R; Landi S
Can J Surg; 1980 Sep; 23(5):429-31. PubMed ID: 6159957
[TBL] [Abstract][Full Text] [Related]
3. Postoperative immunochemotherapy (BCG + 5-FU) in advanced gastric cancer.
Popiela T; Zembala M; Kulig J; Czupryna A; Uracz W
Anticancer Res; 1988; 8(6):1423-7. PubMed ID: 3064717
[TBL] [Abstract][Full Text] [Related]
4. Combination chemoimmunotherapy for advanced gastric carcinoma.
Akiyoshi T; Kawaguchi M; Arinaga S; Miyazaki S; Koba F; Wada T; Tsuji H
Jpn J Surg; 1984 May; 14(3):185-90. PubMed ID: 6431164
[TBL] [Abstract][Full Text] [Related]
5. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results.
Mavligit GM; Gutterman JU; Burgess MA; Khankhanian N; Seibert GB; Speer JF; Reed RC; Jubert AV; Martin RC; McBride CM; Copeland EM; Gehan EA; Hersh EM
Cancer; 1975 Dec; 36(6 Suppl):2421-7. PubMed ID: 1212660
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival.
Mavligit GM; Gutterman JU; Malahy MA; Burgess MA; McBride CM; Jubert A; Hersh EM
Cancer; 1977 Nov; 40(5 Suppl):2726-30. PubMed ID: 922710
[TBL] [Abstract][Full Text] [Related]
8. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
Yap HY; Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Krutchik AN; Benjamin RS; Gutterman JU; Bodey GP
J Surg Oncol; 1979 Dec; 12(4):333-41. PubMed ID: 392197
[TBL] [Abstract][Full Text] [Related]
9. [Twenty-year experience with multimodal treatment of gastric cancer patients in Poland].
Popiela T; Kulig J; Kolodziejcyk P;
Zentralbl Chir; 2001 Oct; 126(10):763-71. PubMed ID: 11727184
[TBL] [Abstract][Full Text] [Related]
10. Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up.
Jeung HC; Moon YW; Rha SY; Yoo NC; Roh JK; Noh SH; Min JS; Kim BS; Chung HC
Ann Oncol; 2008 Mar; 19(3):520-6. PubMed ID: 18029971
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of chemoimmunotherapy for resectable and non-resectable gastrointestinal cancer.
Ambus U; Falk RE; Landi S; Bugala R; Langer B
Dev Biol Stand; 1977 Apr 13-15; 38():541-5. PubMed ID: 344107
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of postoperative immunotherapy of gastric cancer].
Ochiai T; Sato H
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):373-9. PubMed ID: 6349536
[TBL] [Abstract][Full Text] [Related]
13. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
Buzdar AU; Gutterman JU; Blumenschein GR; Hortobagyi GN; Tashima CK; Smith TL; Hersh EM; Freireich EJ; Gehan EA
Cancer; 1978 Mar; 41(3):1064-75. PubMed ID: 638948
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with BCG and chemotherapy for metastatic gastrointestinal cancer.
Falk RE; MacGregor AB; Ambus U; Landi S; Miller AB; Samuel ES; Langer B
Dis Colon Rectum; 1977 Apr; 20(3):215-22. PubMed ID: 849691
[TBL] [Abstract][Full Text] [Related]
15. Combined 5-fluorouracil (5-FU) and radiation therapy following resection of locally advanced gastric carcinoma.
Gez E; Sulkes A; Yablonsky-Peretz T; Weshler Z
J Surg Oncol; 1986 Feb; 31(2):139-42. PubMed ID: 3713191
[TBL] [Abstract][Full Text] [Related]
16. Preoperative endoscopic intratumor application of tumor necrosis factor alpha in patients with locally advanced resectable gastric cancer.
Karcz D; Popiela T; Szczepanik AM; Czupryna A; Szymanska B; Siedlar M; Zembala M
Endoscopy; 1994 May; 26(4):369-70. PubMed ID: 8076575
[No Abstract] [Full Text] [Related]
17. A trial of adjuvant combination chemoimmunotherapy for stage III carcinoma of stomach.
Akiyoshi T; Kawaguchi M; Arinaga S; Miyazaki S; Koba F; Wada T; Tsuji H
J Surg Oncol; 1984 Jun; 26(2):86-90. PubMed ID: 6429448
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M
Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772
[TBL] [Abstract][Full Text] [Related]
19. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
20. Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
Dos Santos M; Lequesne J; Leconte A; Corbinais S; Parzy A; Guilloit JM; Varatharajah S; Brachet PE; Dorbeau M; Vaur D; Weiswald LB; Poulain L; Le Gallic C; Castera-Tellier M; Galais MP; Clarisse B
BMC Cancer; 2022 May; 22(1):537. PubMed ID: 35549674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
